Clinical Trials Directory

Trials / Completed

CompletedNCT05380128

Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population

Association Study Between Vitamin D Receptor Gene Polymorphisms and Risk and Features of Myasthenia Gravis in Han Chinese Population

Status
Completed
Phase
Study type
Observational
Enrollment
297 (actual)
Sponsor
Beijing Tongren Hospital · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

The Vitamin D receptor gene (VDR) polymorphisms are the candidate genetic variants for susceptibility to autoimmune diseases. In the present study, the investigators aimed to assess the association between VDR polymorphisms and myasthenia gravis (MG) susceptibility and disease features in Chinese Han population.The patients with MG and healthy controls were genotyped for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms using the improved multiple ligase detection reaction. Information on age at onset, acetylcholine receptor antibody (AChR-Ab) and muscle-specific kinase antibody (MuSK-Ab) status, thymus status, involved muscles at onset and Osserman type at the maximum worsening during 2 years follow-up were obtained and used as the grouping basis of sub-classifications. Intergroup comparisons of allele and genotype frequencies, haplotype distributions were performed between MG group and the control group, and between each pair of MG subgroups.

Conditions

Interventions

TypeNameDescription
GENETICGenotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphismsGenomic DNA was extracted from peripheral blood samples using a Wizard Genomic DNA Purification Kit (Promega, Madison,Wisconsin, USA) as per the product instruction. VDR (rs731236, rs1544410, rs7975232, rs2228570) polymorphisms were genotyped by the improved Multiple Ligase Detection Reaction (iMLDR) developed by Genesky Biotechnologies Inc. (Shanghai, China).

Timeline

Start date
2017-06-01
Primary completion
2019-12-31
Completion
2022-05-09
First posted
2022-05-18
Last updated
2022-05-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05380128. Inclusion in this directory is not an endorsement.